已收盘 01-30 16:00:00 美东时间
+4.350
+4.60%
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-30 21:17
Needham analyst Kyle Peterson maintains Axos Financial (NYSE:AX) with a Buy and raises the price target from $107 to $110.
01-30 19:54
Keefe, Bruyette & Woods analyst Kelly Motta maintains Axos Financial (NYSE:AX) with a Market Perform and raises the price target from $100 to $110.
01-30 19:52
U.S. RESEARCH ROUNDUP-Definium Therapeutics, Kenvue, Werner Enterprises Jan 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Definium Therapeutics, Kenvue and Werner Enterprises on Friday. HIGHLIGHTS * Ameriprise Finan
01-30 15:45
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 基于Axos Financial业绩会实录,以下是2025年12月31日结束季度的业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 净利息收入:3.316亿美元,环比增长4,100万美元,增幅14% - 非利息收入:5,340万美元,环比增长65%,主要受Verdant收购贡献1,890万美元推动 - 净利润:1.284亿美元,同比增长22.6%(上年同期1.047亿美元) - 每股收益:2.22美元,同比增长23.3%(上年同期1.80美元) **资产负债表:** - 贷款净增长:10亿美元(环比) - 存款余额:232亿美元,环比增长
01-30 12:16
Axos Financial beats Q2 profit estimates Overview Banking firm's fiscal Q2 adjusted EPS beat analysts' expectations Net interest income rose 18.4% yr/yr Non-interest income surged 92% yr/yr, boosted by Verdant acquisition Outlook Company did not provide specific guidance for future quarters or the f
01-30 05:16
Axos Financial (NYSE:AX) released its Q2 earnings on Thursday, January 29, 2026...
01-30 05:08
BRIEF-Axos Financial Q2 Adjusted EPS USD 2.25 Vs. IBES Estimate USD 2.09 Jan 29 (Reuters) - Axos Financial Q2 net interest income USD 331.709 million. Q2 net income USD 128.397 million Q2 EPS USD 2.22 Q2 adjusted net income USD 130.167 million vs. IBES estimate USD 120.6 million
01-30 05:05
Companies Reporting Before The Bell • MOGU (NYSE:MOGU) is estimated to report e...
01-29 19:11
今日重点评级关注:Guggenheim:维持MBX Biosciences"买入"评级,目标价从77美元升至88美元;摩根士丹利:维持DraftKings"超配"评级,目标价从50美元升至53美元
01-20 10:26